The effect of dexmedetomidine on acute kidney injury after elective major abdominal surgery : a retrospective single-center propensity score matched study

Abstract Background Major abdominal surgery is a kind of high-risk surgery type for postoperative acute kidney injury (AKI) among non-cardiac surgeries. Despite dexmedetomidine exerts significant renal protective effects in cardiac surgeries and animal studies, whether it is associated with a lower...

Full description

Saved in:
Bibliographic Details
Main Authors: Haibei Liu, Rong Luo, Liu Qian, Yujun Zhang, Wensheng Zhang, Juan Tan, Ling Ye
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Anesthesiology
Subjects:
Online Access:https://doi.org/10.1186/s12871-024-02845-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850254090933633024
author Haibei Liu
Rong Luo
Liu Qian
Yujun Zhang
Wensheng Zhang
Juan Tan
Ling Ye
author_facet Haibei Liu
Rong Luo
Liu Qian
Yujun Zhang
Wensheng Zhang
Juan Tan
Ling Ye
author_sort Haibei Liu
collection DOAJ
description Abstract Background Major abdominal surgery is a kind of high-risk surgery type for postoperative acute kidney injury (AKI) among non-cardiac surgeries. Despite dexmedetomidine exerts significant renal protective effects in cardiac surgeries and animal studies, whether it is associated with a lower incidence of AKI in major abdominal surgeries remains unclear. Methods From January 2019 to July 2021, patients undergoing elective major abdominal surgery in West China Hospital were enrolled. Participants were divided into two groups based on exposure to continuous intravenous dexmedetomidine: the Dex group (exposed) and the Control group (not exposed). The primary outcome was the incidence of AKI in the postoperative 7 days. Secondary outcomes included intraopertive average urine output, renal function on the first day after surgery, incidence of postoperative dialysis, postoperative intensive care unit (ICU) admission, in-hospital mortality, length of hospital stay, incidence of intraoperative hypotension and bradycardia, and intraoperative use of inotropes and vasopressors. Propensity score matching (PSM), based on participants’ baseline and intraoperative characteristics, was performed to minimize potential bias. Furthermore, a subgroup analysis was conducted based on the infusion rate and the use of a loading dose to explore the effects of different methods of dexmedetomidine administration on AKI. The subgroups included: loading dose, non-loading dose, low-infusion rate (infusion rate ≤ 0.4 µg/kg/h), and high-infusion rate (infusion rate > 0.4 µg/kg/h). Results After PSM with a ratio of 1:1, a total of 8836 patients were successfully matched. Dexmedetomidine administration had no association with the incidence of postoperative AKI, serum creatinine (Scr) level on the first postoperative day, incidence of postoperative dialysis, postoperative ICU admission, in-hospital mortality, length of hospital stay, intraoperative hypotension, or the use of inotropes and vasopressors, but had association with increased intraoperative average urine output (122.95 (76.80, 189.27) vs. 104.65 (67.04, 161.07) ml/h, P < 0.001), higher value of estimated glomerular filtration rate (eGFR) (97.33 ± 15.95 vs. 96.13 ± 16.35 ml/min/1.73m2, P < 0.001) on the first day after surgery and a higher incidence of intraoperative bradycardia (37.0% vs. 30.6%; P < 0.001). In the loading dose subgroup, dexmedetomidine use was significantly associated with a reduced incidence of postoperative AKI (odds ratio (OR): 0.44, 95% confidence interval (CI): 0.23–0.76, P = 0.006).The association between dexmedetomidine and postoperative AKI was absent in subgroups of high or low infusion rate and no loading dose use. Conclusion In this single-center retrospective propensity-matched study, we did not detect a significant overall difference in post-operative AKI rates between patients treated with or without dexmedetomidine during major abdominal surgery. However, though additional prospective data are needed, our study found that administering dexmedetomidine with a loading dose may be associated with lower rates of AKI, potentially indicating a renoprotective effect of loading-dose dexmedetomidine in this setting.
format Article
id doaj-art-c4d5d58c604b4d2f8ce5ca2c84c36c6a
institution OA Journals
issn 1471-2253
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series BMC Anesthesiology
spelling doaj-art-c4d5d58c604b4d2f8ce5ca2c84c36c6a2025-08-20T01:57:12ZengBMCBMC Anesthesiology1471-22532024-12-0124111310.1186/s12871-024-02845-7The effect of dexmedetomidine on acute kidney injury after elective major abdominal surgery : a retrospective single-center propensity score matched studyHaibei Liu0Rong Luo1Liu Qian2Yujun Zhang3Wensheng Zhang4Juan Tan5Ling Ye6Department of Anesthesiology, West China Hospital, Sichuan UniversityDepartment of Anesthesiology, West China Hospital, Sichuan UniversityDepartment of Anesthesiology, West China Hospital, Sichuan UniversityDepartment of Anesthesiology, West China Hospital, Sichuan UniversityDepartment of Anesthesiology, West China Hospital, Sichuan UniversityDepartment of Anesthesiology, Chengdu Third People’s Hospital, Sichuan UniversityLaboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Center of Translational Medicine of Anesthesiology, West China Hospital, Sichuan UniversityAbstract Background Major abdominal surgery is a kind of high-risk surgery type for postoperative acute kidney injury (AKI) among non-cardiac surgeries. Despite dexmedetomidine exerts significant renal protective effects in cardiac surgeries and animal studies, whether it is associated with a lower incidence of AKI in major abdominal surgeries remains unclear. Methods From January 2019 to July 2021, patients undergoing elective major abdominal surgery in West China Hospital were enrolled. Participants were divided into two groups based on exposure to continuous intravenous dexmedetomidine: the Dex group (exposed) and the Control group (not exposed). The primary outcome was the incidence of AKI in the postoperative 7 days. Secondary outcomes included intraopertive average urine output, renal function on the first day after surgery, incidence of postoperative dialysis, postoperative intensive care unit (ICU) admission, in-hospital mortality, length of hospital stay, incidence of intraoperative hypotension and bradycardia, and intraoperative use of inotropes and vasopressors. Propensity score matching (PSM), based on participants’ baseline and intraoperative characteristics, was performed to minimize potential bias. Furthermore, a subgroup analysis was conducted based on the infusion rate and the use of a loading dose to explore the effects of different methods of dexmedetomidine administration on AKI. The subgroups included: loading dose, non-loading dose, low-infusion rate (infusion rate ≤ 0.4 µg/kg/h), and high-infusion rate (infusion rate > 0.4 µg/kg/h). Results After PSM with a ratio of 1:1, a total of 8836 patients were successfully matched. Dexmedetomidine administration had no association with the incidence of postoperative AKI, serum creatinine (Scr) level on the first postoperative day, incidence of postoperative dialysis, postoperative ICU admission, in-hospital mortality, length of hospital stay, intraoperative hypotension, or the use of inotropes and vasopressors, but had association with increased intraoperative average urine output (122.95 (76.80, 189.27) vs. 104.65 (67.04, 161.07) ml/h, P < 0.001), higher value of estimated glomerular filtration rate (eGFR) (97.33 ± 15.95 vs. 96.13 ± 16.35 ml/min/1.73m2, P < 0.001) on the first day after surgery and a higher incidence of intraoperative bradycardia (37.0% vs. 30.6%; P < 0.001). In the loading dose subgroup, dexmedetomidine use was significantly associated with a reduced incidence of postoperative AKI (odds ratio (OR): 0.44, 95% confidence interval (CI): 0.23–0.76, P = 0.006).The association between dexmedetomidine and postoperative AKI was absent in subgroups of high or low infusion rate and no loading dose use. Conclusion In this single-center retrospective propensity-matched study, we did not detect a significant overall difference in post-operative AKI rates between patients treated with or without dexmedetomidine during major abdominal surgery. However, though additional prospective data are needed, our study found that administering dexmedetomidine with a loading dose may be associated with lower rates of AKI, potentially indicating a renoprotective effect of loading-dose dexmedetomidine in this setting.https://doi.org/10.1186/s12871-024-02845-7DexmedetomidineAdultAcute kidney injuryMajor abdominal surgery
spellingShingle Haibei Liu
Rong Luo
Liu Qian
Yujun Zhang
Wensheng Zhang
Juan Tan
Ling Ye
The effect of dexmedetomidine on acute kidney injury after elective major abdominal surgery : a retrospective single-center propensity score matched study
BMC Anesthesiology
Dexmedetomidine
Adult
Acute kidney injury
Major abdominal surgery
title The effect of dexmedetomidine on acute kidney injury after elective major abdominal surgery : a retrospective single-center propensity score matched study
title_full The effect of dexmedetomidine on acute kidney injury after elective major abdominal surgery : a retrospective single-center propensity score matched study
title_fullStr The effect of dexmedetomidine on acute kidney injury after elective major abdominal surgery : a retrospective single-center propensity score matched study
title_full_unstemmed The effect of dexmedetomidine on acute kidney injury after elective major abdominal surgery : a retrospective single-center propensity score matched study
title_short The effect of dexmedetomidine on acute kidney injury after elective major abdominal surgery : a retrospective single-center propensity score matched study
title_sort effect of dexmedetomidine on acute kidney injury after elective major abdominal surgery a retrospective single center propensity score matched study
topic Dexmedetomidine
Adult
Acute kidney injury
Major abdominal surgery
url https://doi.org/10.1186/s12871-024-02845-7
work_keys_str_mv AT haibeiliu theeffectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT rongluo theeffectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT liuqian theeffectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT yujunzhang theeffectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT wenshengzhang theeffectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT juantan theeffectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT lingye theeffectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT haibeiliu effectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT rongluo effectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT liuqian effectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT yujunzhang effectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT wenshengzhang effectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT juantan effectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy
AT lingye effectofdexmedetomidineonacutekidneyinjuryafterelectivemajorabdominalsurgeryaretrospectivesinglecenterpropensityscorematchedstudy